TSHA (Taysha) Total Business Assets

Corporate emblem and logo of Taysha Gene Therapies Inc (TSHA)

Taysha Gene Therapies (TSHA) ensures the continuity of its research through verified biomedical pathways and a network of reliable laboratories. The company relies on advanced gene delivery methods to the brain to combat CNS pathologies. The price action of total assets, reaching 401.91, confirms the business potential. Long-term trials and patent protection transform approved drugs into a stable cash cow for years to come.

TSHA - Taysha Gene Therapies Company Total Assets over the range 07/04/2022 - 11/01/2026

Financial and market metric breakdowns for Taysha (TSHA)

- market value and analyst target forecast:
Stock Price tayshagtx.com|TSHA - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Taysha Corp|TSHA - Total Company Value
- book capitalization information:
Equity per Share Taysha Gene Therapies|TSHA - Book Capitalization|Market Capitalization to Book Value Ratio tayshagtx.com|TSHA - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Capital Taysha Gene Therapies|TSHA - Long-Term Debt to Capital|Short-Term Debt to Capital Taysha Corp|TSHA - Company Total Debt|Debts to Book Value Taysha Corp|TSHA - Company Long-Term Debt|Short-Term Debt Volume Taysha Gene Therapies|Intermediate Coverage Ratio tayshagtx.com
- earnings and market ratios statistics:
TSHA - Net Profit
Summary company analysis:TSHA tayshagtx.com
Flagship merchandise of Taysha

Total assets represent the aggregate resource base of the enterprise, determining its ability to sustain operational activities and investment programs. This metric is reverse-calculated via daily ROA and market capitalization; consequently, the total asset value reacts sharply to changes in the valuation of Taysha Gene Therapies (TSHA) amid clinical trial risks and a liquidity shortage for financing Rett syndrome therapy.

Main competitors

Tempus AI, Inc (TEM) - Company Total Assets|QGEN (Qiagen) - Company Total Assets|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Aggregate Company Assets Repligen Corp. (RGEN)|Avidity Corp - Total Business Assets|Company Total Assets CRSP (CRISPR Therapeutics AG)|Company Total Assets genedx.com WGS|RARE: Cumulative Company Assets|Beam Therapeutics Inc - Aggregate Business Assets|SRPT: Company Total Assets|Twist Bioscience Corp (TWST) - Company Total Assets|Cumulative Company Assets TXG|Company Assets intelliatx.com NTLA|Aggregate Company Assets Stoke Therapeutics, Inc. (STOK)|Company Total Asset Base BioLife Solutions Inc|Company Total Assets WVE (Wave Life Sciences Corp)|Aggregate Asset Value MAZE|Sionna Therapeutics Inc - Company Total Assets|PRME - Company Total Assets|QURE (uniQure) - Cumulative Company Assets|MeiraGTx Holdings - Aggregate Asset Value|RGNX (Regenxbio) - Company Total Assets|SLDB - Company Balance Sheet Assets|Company Total Assets OCGN|PACB - Company Assets|Aggregate Company Assets Benitec Biopharma BNTC|DSGN: Total Business Assets|Rocket Pharmaceuticals Inc - Company Total Assets|Company Assets 4D Molecular Corp|LXEO (lexeotx.com) - Cumulative Company Assets|Korro Bio - Aggregate Asset Value|Cumulative Company Assets EDIT|SLN (Silence Therapeutics PLC) - Aggregate Business Assets|Company Total Assets PRQR|CDXS (codexis.com) - Aggregate Asset Value|Company Total Assets SGMO (Sangamo Therapeutics)|Nautilus Biotechnology, Inc. (NAUT) - Company Assets|MGX - Aggregate Company Assets|Aggregate Asset Value DTIL (precisionbiosciences.com)|GBIO: Company Total Assets|Boundless Bio Inc (BOLD) - Company Total Assets|Aggregate Company Assets Exicure Inc.|Celsion Corporation - Total Asset Value of Company|Company Total Assets PHIO|Company Total Asset Base mustangbio.com|Company Total Assets RNAZ (TransCode Therapeutics, Inc.)|Bionano Genomics Inc. (BNGO) - Company Assets|APDN - Aggregate Company Assets|Company Total Asset Base bluebirdbio.com BLUE|IPA (immunoprecise.com) - Cumulative Company Assets|OMGA: Aggregate Business Assets|Aggregate Company Assets Singular Genomics Systems Inc|Regulus (RGLS) - Company Total Asset Base|Company Total Assets SYRS|TBIO (telesisbio.com) - Aggregate Asset Value|Company Total Assets TCON (TRACON Pharmaceuticals, Inc.)|Company Total Assets Unity Biotechnology Inc. UBX